Listed company (major shareholder of other listed companies)
| Company | Shares | Stake | Price | Value | Dividends |
|---|---|---|---|---|---|
| Santen Pharmaceutical Co.,Ltd. 4536 · FY ending Mar 2026 |
6,204,000 | 1.93% | ¥1,788 | ¥11.1B | ¥236M |
| Nippon Fine Chemical Co., Ltd. 4362 · FY ending Mar 2026 |
394,000 | 1.82% | ¥2,431 | ¥958M | ¥38.6M |
| Carna Biosciences, Inc. 4572 · FY ending Dec 2025 |
504,500 | 2.63% | — | — | — |